Standard Operating Procedure for Emergency Medical Handling in BE Units
Department | BA-BE Studies |
---|---|
SOP No. | SOP/BA-BE/092/2025 |
Supersedes | SOP/BA-BE/092/2022 |
Page No. | Page 1 of 10 |
Issue Date | 17/04/2025 |
Effective Date | 20/04/2025 |
Review Date | 17/04/2026 |
1. Purpose
To outline a clear and systematic approach for identifying, responding to, and managing medical emergencies that occur in Bioequivalence (BE) units during the conduct of BA/BE studies, ensuring subject safety, prompt medical intervention, and documentation in compliance with ethical and regulatory standards.
2. Scope
This SOP applies to all clinical staff, physicians, nurses, and emergency responders involved in BA/BE studies at clinical research facilities
3. Responsibilities
- Study Physician: Leads emergency response and determines clinical management.
- Clinical Research Coordinator (CRC): Assists physician, maintains documentation, and communicates with relevant stakeholders.
- Nursing Staff: Provides immediate care, administers first aid or emergency drugs as instructed.
- QA Officer: Ensures all events are documented and reported appropriately.
4. Accountability
The Principal Investigator (PI) is accountable for overseeing the implementation of emergency procedures, post-event follow-up, and compliance with reporting obligations to regulatory authorities and Ethics Committees.
5. Procedure
5.1 Preparedness and Infrastructure
- Ensure availability of:
- Emergency crash cart with life-saving medications
- Functional oxygen cylinders and defibrillator
- First aid kit and IV infusion sets
- Check emergency equipment daily and log in Annexure-1: Emergency Equipment Checklist.
- Display emergency contact numbers and local hospital details in BE unit premises.
5.2 Identification of Medical Emergency
- Medical emergencies may include:
- Severe allergic reactions (e.g., anaphylaxis)
- Chest pain, convulsions, fainting
- Uncontrolled vomiting, abnormal vitals, or unconsciousness
- Any staff member identifying a potential emergency must immediately alert the physician and activate the emergency response system.
5.3 Initial Emergency Response
- Physician to assess and initiate emergency care:
- Administer medication as per medical need
- Ensure airway, breathing, and circulation (ABCs)
- Monitor vitals continuously
- Record observations in Annexure-2: Emergency Medical Handling Record.
5.4 External Referral and Hospitalization
- If required, transfer subject to the designated hospital:
- Use ambulance service
- Send all relevant documents including study protocol, informed consent, and vitals chart
- Update sponsor, Ethics Committee, and regulatory body as per reporting timelines.
5.5 Documentation and Reporting
- Document complete chronology of the event in:
- Annexure-2: Emergency Medical Handling Record
- Annexure-3: Serious Adverse Event (SAE) Form (if applicable)
- Report SAEs within 24 hours to Ethics Committee and sponsor.
5.6 Follow-up and Root Cause Analysis
- Conduct medical follow-up until resolution or stabilization.
- Perform Root Cause Analysis (RCA) and document in Annexure-4: Emergency Event Investigation Form.
- Implement corrective and preventive actions as required.
6. Abbreviations
- BA: Bioavailability
- BE: Bioequivalence
- CRC: Clinical Research Coordinator
- PI: Principal Investigator
- SAE: Serious Adverse Event
- RCA: Root Cause Analysis
7. Documents
- Emergency Equipment Checklist – Annexure-1
- Emergency Medical Handling Record – Annexure-2
- SAE Form – Annexure-3
- Emergency Event Investigation Form – Annexure-4
8. References
- ICH E6(R2) – Good Clinical Practice
- Indian GCP Guidelines
- Schedule Y – Drugs & Cosmetics Rules
9. SOP Version
Version: 2.0
10. Approval Section
Prepared By | Checked By | Approved By | |
---|---|---|---|
Signature | |||
Date | |||
Name | |||
Designation | |||
Department |
11. Annexures
Annexure-1: Emergency Equipment Checklist
Date | Item | Status | Checked By |
---|---|---|---|
17/04/2025 | Oxygen Cylinder | Available | Ravi Nair |
Annexure-2: Emergency Medical Handling Record
Subject ID | Date | Event Description | Actions Taken | Outcome | Handled By |
---|---|---|---|---|---|
VOL-092 | 17/04/2025 | Severe nausea post-dose | IV antiemetic administered | Resolved | Dr. A. Shah |
Annexure-3: SAE Form
Subject ID | Event | Onset Date | Reported To | Initial Report Date |
---|---|---|---|---|
VOL-092 | Severe Vomiting | 17/04/2025 | EC/Sponsor | 17/04/2025 |
Annexure-4: Emergency Event Investigation Form
Event | Root Cause | Corrective Action | Preventive Action | Verified By |
---|---|---|---|---|
Unconsciousness | Drug sensitivity | Withheld further dose | Pre-dose allergy screening | QA Officer |
Revision History:
Revision Date | Revision No. | Details | Reason | Approved By |
---|---|---|---|---|
14/01/2022 | 1.0 | Initial SOP Release | Safety Process | QA Head |
17/04/2025 | 2.0 | Added structured forms and referral procedures | Regulatory Compliance | QA Head |